Retinopati Diabetes
DOI:
https://doi.org/10.55175/cdk.v46i3.501Keywords:
Diabetes melitus, kebutaan, retinopati diabetesAbstract
Retinopati diabetes (RD) merupakan kelainan retina pada pasien diabetes melitus dan menjadi penyebab utama kebutaan pada usia produktif di negara Barat. Kejadian RD pada populasi diabetes meningkat seiring durasi penyakit. Selain pengendalian gula darah, tindakan invasif berupa fotokoagulasi laser, injeksi anti-VEGF, atau tindakan bedah, mungkin diperlukan sesuai derajat keparahan RD. Skrining pada pasien DM diperlukan agar mendapat penanganan yang cepat dan tepat. Artikel ini membahas patofisiologi dan tatalaksana retinopati diabetes.
Diabetic retinopathy (DR) is a retinal disorder in patients with diabetes mellitus and one of the leading causes blindness in Western world, particularly among working-age individuals. The incidence of DR was increased along with the duration of disease. Along with blood sugar control, invasive procedures such as laser photocoagulation, anti-VEGF injection, or surgery may be needed. Eye screening in diabetic patient is needed to provide prompt treatment. The pathophysiology and treatment of diabetic retinopathy will be discussed.
Downloads
References
Ilyas S. Ilmu penyakit mata. 3rd Ed. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2008.
American Academy of Ophthalmology. Retina and vitreous in basic and clinical science course. 2015-2016.
Riordan-Eva P, Cunningham ET. Vaughan & Asbury’s general ophthalmology. 18th ed. New York: Mc Graw Hill; 2011.
Pusat Data dan Informasi Kementrian Kesehatan Indonesia. Waspada diabetes. Jakarta; 2014.
Eshaq RS, Aldalati AMZ, Alexander JS, Harris NR. Diabetic retinopathy: Breaking the barrier. Pathophysiology. 2017;24(4):229-41.
Tarr JM, Kaul K, Chopra M, Kohner EM, Chibber R. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2013;2013:343560.
Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038.
Cen S, Hsu Y, Lin Y, Huang YC, Chen CJ, Lin WD, et al. Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan. Biomedicine. 2016; 6:1-8.
Ahsan H. Diabetic retinopathy-biomolecules and multiple pathophysiology. Diab Met Syndr: Clin Res Rev. 2014.
Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, et al. Pan-retinal photocoagulation and other forms of laser treatment and drugs therapies for nonproliferative diabetic retinopathy: Systemic review and economic evaluation. Health Technol Assess. 2015;19(51):v-xxviii, 1-247
Antonetti DA, Klein R, Gardner TW. Mechanisms of disease diabetic retinopathy. NEJM. 2012;13:1227-39.
Midena E, Bini S. Multimodal retinal imaging of diabetic macular edema: Toward new paradigms of pathophysiology. Graefes Arch Clin Exp Ophthalmol. 2016;254(9):1661-8.
Helmy YM, Allah HRA. Optical coherence tomography classification of diabetic cystoid macular edema. Clin Ophthalmol. 2013;7:1731-7.
Diabetic macular oedema based on optical coherence tomography and fluorescein angiography. Br J Ophthalmol. 2014;98:1612-7.
Qian T, Zhao M, Li X, Xu X. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: A systematic review and meta-analysis. Int J Ophthalmol. 2017;10:1134-43.
Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E.. Anti-vascular endothelial growth factor diabetic macular oedema: A network meta-analysis. Cochrane Database Syst Rev. 2017;6:CD007419.
Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol. 2012;2012:852183.
Regillo CD, Gallanan DG, DO DV, Fine HF, Holekamp NM, Kuppermann BD, et al. Use of corticosteroid in the treatment of patients with diabetic macular edema who have a suboprimal response to anti-VEGF: Recommendations of an expert panel. Ophthalmic Surgery, Lasers & Imaging Retina. 2017;48(4):291-301.
Garg S, Davis RM. Diabetic retinopathy screening update. Clin Diabetes, 2009;27(4):140-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
